Prevalence of multi drug resistant Acinetobacter baumannii in the clinical samples from tertiary care hospital in Islamabad, Pakistan

Pakistan Journal of Medical Sciences

Volumn 29, Issue 5, 2013, Pages

  Begum, Shahzeera ^a   Hasan, Fariha ^a   Hussain, Shagufta ^b   Shah, Aamer Ali ^a  

^a QUAID I AZAM UNIVERSITY   (Pakistan)

^b PAKISTAN INSTITUTE OF MEDICAL SCIENCES   (Pakistan)

Author keywords

Acinetobacter baumannii; AmpC lactamases; Carbapenemases; Extended spectrum lactamases; Minimal inhibitory concentration; Multi drug resistant

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE AMPC; CARBAPENEMASE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; DOXYCYCLINE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; MINOCYCLINE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; SULTAMICILLIN; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; ENZYME SYNTHESIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NEWBORN; NONHUMAN; PAKISTAN; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; TERTIARY HEALTH CARE;

EID: 84881527451     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hidron AI, Edwards JR, Patel J. NHSN annual update: antimicrobial-resistant pathogens associated with health care associated infect ions: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevent ion, 2006-2007. Infect Control Hosp Epidemiol. 2008;29:996-1011.
2. Afreenish H, Javaid U, Fatima K, Aslam K, Zakir H. In vitro activity of aminoglycosides, β-lactam-β-lactamases inhibitor combinations and tetracyclines against multi-drug resistant Acinetobacter baumannii, isolated from a tertiary care hospital. J Microbiol Antimicrob. 2010;2(4):47-50.
3. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo PN. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51:3471-384.
4. Siegel RE. Emerging gram-negative antibiotic resistance: daunting challenges, declining sensitivities, and dire consequences. Respir Care. 2008;53(4):471-479.
5. Maragakis LL, Perl TM. Acinetobacter baumannii: Epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis. 2008;46(8):1254-1263.
6. Anton, Y, Seifert PH, Paterson DL. Acinetobacter baumannii: Emergence of a Successful Pathogen. Clin Microbiol Rev. 2008;3(21):538-582.
7. Sirot J. Detection of extended-spectrum plasmid-mediated β-lactamases by disk diffusion. Clin Microbiol Infect. 1996;2(S):35-39.
8. Lee K, Chong Y, Shin HB, Kim YA, Yong D, Yum JH. Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect. 2001;7:88-91.
9. Black, JA, Moland ES, Thomson KS. AmpC Disk Test for Detection of Plasmid-Mediated AmpC β-Lactamases in Enterobacteraceae Lacking Chromosomal AmpC β-Lactamases. J Clin Microbiol. 2005;43:3110-3113.
10. Shanthi M, Sekar U. Multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii infections among hospitalized patients: risk factors and outcomes. J Assoc Physicians India. 2009;8(11):687-693.
11. Higgins PG, Fluit AC, Milatovic D, Verhoef J, Schmitz FJ. Mutations in GyrA, ParC, MexR, and NfxB in clinical isolates of Pseudomonas aeruginosa. Int J Antimicro Agents. 2003;21:409-413.
12. Swenson JM, Killgore GE, Tenover FC. Antimicrobial susceptibility testing of Acinetobacter spp. by NCCLS broth micro dilution and disk diffusion methods. J Clin Microbiol. 2004;42:5102-5108.
13. Joshi SG, Litake GM, Ghole VS, Niphadkar KB. Plasmid borne extended spectrum b lactamase in a clinical isolate of Acinetobacter baumannii. J Med Microbiol. 2003;52:1125-1127.
14. Mahua S, Srinivasa H, Macaden R. Antibiotic resistance profile & extended spectrum beta-lactamase (ESBL) production in Acinetobacter species. Indian J Med Res. 2007;126:63-67.
15. Aubert D, Poirel L, Ali AB, Goldstein FW, Nordmann P. OXA-35 is an OXA-10-related bête-lactamase from Pseudomonas aeruginosa. J Antimicrob Chemother. 2001;48:717-721.
16. Walther-Rasmussen J, Hoiby N. OXA-type carbapenemases. J Antimicrob Chemother. 2006;57:373-383.
17. Rasmussen BA, Bush K. Carbapenem-hydrolyzing β-lactamases. Antimicrob Agents Chemother. 1997;41:223-232.
18. Heritier C, Poirel L, Lambert T, Nordmann P. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 2005;49:3198-3202.